Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016

Lilian T. Gien, Danielle M. Enserro, Matthew S. Block, Steven Waggoner, Linda R. Duska, Andrea E. Wahner-Hendrickson, Premal H. Thaker, Floor Backes, Michael Kidd, Carolyn Y. Muller, Paul A. DiSilvestro, Allan Covens, David M. Gershenson, Kathleen N. Moore, Carol Aghajanian, Robert L. Coleman